Halozyme Therapeutics shares owned by Baird Financial
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Baird Financial
from 13F filings
Historical chart of Baird Financial investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Baird Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Baird Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.7M | 128k | 36.96 |
| 2023-09-30 | $3.2M | 84k | 38.20 |
| 2023-06-30 | $3.0M | 84k | 36.07 |
| 2023-03-31 | $2.9M | 75k | 38.19 |
| 2022-12-31 | $4.2M | 73k | 56.91 |
| 2022-09-30 | $2.9M | 72k | 39.53 |
| 2022-06-30 | $3.1M | 71k | 44.01 |
| 2022-03-31 | $2.7M | 67k | 39.87 |
| 2021-12-31 | $2.4M | 60k | 40.22 |
| 2021-09-30 | $2.4M | 59k | 40.68 |
| 2021-06-30 | $2.0M | 43k | 45.41 |
| 2021-03-31 | $1.3M | 30k | 41.68 |
| 2020-12-31 | $978k | 23k | 42.72 |
| 2020-06-30 | $320k | 12k | 26.78 |